Diaceutics plc (DXRX)
LSE
Closed
Oct 5, 2026
Day's Range
192.0052 wk Range
125.00Overview - DXRX - Diaceutics plc
Key Statistics
Valuation
Enterprise Value
127.57M
P/E (Trailing)
‪105.00‬
P/E (Forward)
‪38.95‬
PEG Ratio
‪38.95‬
Price / Sales (TTM)
‪3.48‬
Price / Book
‪330.54‬
EV / EBITDA
‪31.22‬
Profitability
Profit Margin
‪0.25%‬
Operating Margin
‪13.49%‬
Return on Assets
‪0.05%‬
Return on Equity
‪0.24%‬
Ownership
Shares Outstanding
84.66M
Float
48.77M
Held by Insiders
‪27.81%‬
Held by Institutions
‪64.13%‬
Price stats
Beta
‪0.88‬
50-Day Avg
‪142.32‬
200-Day Avg
‪150.15‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Market Cap - DXRX - Diaceutics plc
Peers - DXRX - Diaceutics plc
Peer Comparison
Compared with companies in Health Information Services listed on LSE.
Profile Summary - DXRX - Diaceutics plc
About
Diaceutics plc provides data analytics and diagnostic commercialization services for the precision medicine industry. The company's primary function is to optimize the development and delivery of precision testing services, essential for determining the appropriate and effective use of medicines, particularly in the…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
